Você está no índice de

Dissertações

Dissertações

Risk factors of Helicobacter pylori infection in an urban community in Northeast Brazil and the relationship between the infection and gastric diseases

Helicobacter pylori is the primary etiologic agent involved in gastric diseases in humans with worldwide distributions. In 2005, H. pylori was identified as a microbiologic contaminant of water, and its role in gastric diseases was further assessed.

Dissertações

Prevalence of infection and Antimicrobial Resistance of Helicobacter pylori isolates from symptomatic patients of Talca Regional Hospital, Chile

Helicobacter pylori, is the causative agent of gastritis, gastric ulcers, gastric cancer and mucosal-associated lymphoid tissue tumor (MALT). There are several treatment schemes for the eradication of this bacterium.

Dissertações

EPIDEMIOLOGICAL STUDY OF Helicobacter pylori INFECTION IN CHILDREN UP TO FIVE YEARS OF AGE IN AN INDIGENOUS COMMUNITY OF SÃO PAULO CITY

Longitudinal studies of Helicobacter pylori infection acquisition during early childhood with diagnosis established by locally validated noninvasive tests are scarce, particularly at high risk populations.

Dissertações

GASTRIC CANCER; THE VILLARRICA HOSPITAL PROGRAM

Chile has a 60 to 80 % rate of Helicobacter infection depending on the region; is no surprise that the mortality rate due to gastric cancer in Chile is one of the highest in America.

Dissertações

Genetic variants associated with Helicobacter pylori infection increase serum pepsinogen 2 level in gastric cancer patients

Little is known about serum diagnostic metabolites relate to H. pylori risk of gastric cancer (GC). We aimed to investigate the association between plasma metabolite concentrations and H. pylori infection and two cohorts of patients at risk and excluded GC.

Dissertações

Polymorphisms in Wnt/beta-catenin pathway are associated with survival of gastric cancer

Gastric cancer (GC) is the sixth most common cancer and the third leading cause of death due to cancer worldwide. More than a half of patients are diagnosed at advanced stage (TNM III), where 5-year overall survival rate is less than 50%.


Apoio Científico